CABS 6/6 event - China delegation, China opportunity, kick-start of E-club
anonymous-100082 06/05 59744.0/1
Gmail
Google+
Calendar
Web
more
Primary
CABS 6/6 speaker info
Y
yan wang
to me
0 minutes ago
Details
About the speakers:
Sheauyu Teddy Hsu, Ph.D.
Dr. Hsu have worked on the discovery and physiology/pharmacology of various hormones and receptors in humans and other vertebrates for over twenty years. Over the years, the beneficial role of many of these hormones in human health has become increasingly apparent. In 2012, Dr. Hsu founded Adpethera LLC to develop and commercialize biologic therapeutics for the treatment of life-threatening diseases. The mission of Adepthera is to translate endocrine knowledge into business that generates first-in-class drugs for unmet medical needs. Currently, the team focuses on the preclinical development of a group of novel hormonal drug candidates for the treatment of life-threatening reproductive disorders, and breast cancer-associated lymphedema.
Jackson Gong,Ph.D.
Qiang (Jackson) Gong is the founder/COO of Aptitude Medical Systems, a biotechnology startup. He has published 10+ peer-reviewed papers and co-invented the patent that serves as the foundation of Aptitude technology. In Aptitude, he led the effort to raise the $1M+ seed funding in 2013 and served as the PI for the $1.7M fast-track SBIR grant in 2014.
Alan Hao, Ph.D.
Dr.Hao is a seasoned medicinal chemist with the passion of discovering innovative medicines to treat diseases with unmet need. He worked on various disease areas including cancer, inflammation, diabetes and obesity in Tularik and Amgen. During his industrial career over the past 15 years, Alan was responsible for providing scientific and technical leadership and strategic direction to the medicinal chemistry projects, and led the medicinal chemistry efforts to move three drug candidates into clinical trials. Most recently, Alan founded AIM Biosciences, with the goal of developing affordable innovative medicines for seriously ill patients. He received his PhD in organic chemistry from the University of Illinois at Chicago and BS from Peking University. He is the current president of CABS.
Cheni Kwok Ph.D
Dr. Cheni Kwok is a Managing Partner of Linear Dreams LLC, a management consultancy and valuation software firm specialized in corporate strategy, business/corporate development, portfolio analysis, and valuation services for the life science industry. Dr Kwok has broad range of operational expertise and established >100 transactions including M&A, strategic partnerships, in/out-licensing, divestitures, spin-offs and project financing. Prior to founding Linear Dreams LLC, Dr Kwok served as the Senior Vice President, Corporate Development at Poniard Pharmaceuticals Inc. and held business development positions of increasing responsibility at Celera Genomics Inc. and Exelixis Inc. Prior to joining Exelixis Inc., Dr. Kwok held various research management, technology assessment and alliance management roles at SmithKline Beecham PLC (now GSK). Dr. Kwok received a Ph.D. in human molecular genetics from the University of Cambridge, UK and the Certified Licensing Professional (CLP) credential awarded by the Licensing Executives Society. Dr Kwok is currently serving as the President of the American Cancer Society’s California Chinese Unit, Vice-President of the Chinese Bioscience Association (CBA) and Co-Chair of Business & Career Development Executive Council of the Chinese-American Biopharmaceutical Society (CABS).
